Bausch + Lomb Corporation, an eye health company responsible for producing popular contact lens brands like Biotrue and Soflens, is planning to go public. Here's what we know—and how to buy Bausch + Lomb Corporation stock in Canada when it launches.
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View Bausch + Lomb's price performance, share price volatility, historical data and technicals.
Historical closes compared with the last close of C$22.35
| 1 week (2024-07-17) | -3.12% |
|---|---|
| 1 month (2024-06-24) | 9.83% |
| 3 months (2024-04-24) | 9.88% |
| 6 months (2024-01-24) | 13.57% |
| 1 year (2023-07-24) | -14.17% |
| 2 years (2022-07-24) | 8.97% |
| 3 years (2021-07-18) | N/A |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Bausch + Lomb P/E ratio, PEG ratio and EBITDA.
Bausch + Lomb's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2157. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bausch + Lomb's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Bausch + Lomb's EBITDA (earnings before interest, taxes, depreciation and amortisation) is C$613 million.
The EBITDA is a measure of Bausch + Lomb's overall financial performance and is widely used to measure a its profitability.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…Steps to owning and managing Yoshitsu Co. stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Cerberus Cyber Sentinel stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Fresh Vine Wine, Inc stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing DGX with 24-hour and historical pricing before you buy.
Everything we know about the Nuvectis Pharma IPO plus information on how to buy in.
Steps to owning and managing BuzzFeed, Inc stocks, with 24-hour and historical pricing before you buy.
These are the best renewable energy stocks to buy now in Canada.
A failed SPAC deal pulled the plug on this vertical farming company’s plans to go public. But you can buy stock in other sustainable farming companies.
Everything we know about the Reddit IPO plus information on how to buy in.
Want to know how to buy and sell stocks in Canada? Find out what you need to know in this simple, step-by-step guide.
